Literature DB >> 2910901

Quantitative measurements of regional glucose utilization and rate of valine incorporation into proteins by double-tracer autoradiography in the rat brain tumor model.

M Kirikae1, M Diksic, Y L Yamamoto.   

Abstract

We examined the rate of glucose utilization and the rate of valine incorporation into proteins using 2-[18F]fluoro-2-deoxyglucose and L-[1-14C]-valine in a rat brain tumor model by quantitative double-tracer autoradiography. We found that in the implanted tumor the rate of valine incorporation into proteins was about 22 times and the rate of glucose utilization was about 1.5 times that in the contralateral cortex. (In the ipsilateral cortex, the tumor had a profound effect on glucose utilization but no effect on the rate of valine incorporation into proteins.) Our findings suggest that it is more useful to measure protein synthesis than glucose utilization to assess the effectiveness of antitumor agents and their toxicity to normal brain tissue. We compared two methods to estimate the rate of valine incorporation: "kinetic" (quantitation done using an operational equation and the average brain rate coefficients) and "washed slices" (unbound labeled valine removed by washing brain slices in 10% trichloroacetic acid). The results were the same using either method. It would seem that the kinetic method can thus be used for quantitative measurement of protein synthesis in brain tumors and normal brain tissue using [11C]-valine with positron emission tomography.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2910901     DOI: 10.1038/jcbfm.1989.12

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  4 in total

1.  Metabolomics: a novel approach to early and noninvasive prostate cancer detection.

Authors:  Matthew J Roberts; Horst J Schirra; Martin F Lavin; Robert A Gardiner
Journal:  Korean J Urol       Date:  2011-02-19

2.  Gain of glucose-independent growth upon metastasis of breast cancer cells to the brain.

Authors:  Jinyu Chen; Ho-Jeong Lee; Xuefeng Wu; Lei Huo; Sun-Jin Kim; Lei Xu; Yan Wang; Junqing He; Lakshmi R Bollu; Guang Gao; Fei Su; James Briggs; Xiaojing Liu; Tamar Melman; John M Asara; Isaiah J Fidler; Lewis C Cantley; Jason W Locasale; Zhang Weihua
Journal:  Cancer Res       Date:  2014-12-15       Impact factor: 12.701

3.  Pharmacokinetics of 11C-labelled BCNU and SarCNU in gliomas studied by PET.

Authors:  S Mitsuki; M Diksic; T Conway; Y L Yamamoto; J G Villemure; W Feindel
Journal:  J Neurooncol       Date:  1991-02       Impact factor: 4.130

Review 4.  Contribution of LAT1-4F2hc in Urological Cancers via Toll-like Receptor and Other Vital Pathways.

Authors:  Xue Zhao; Shinichi Sakamoto; Maihulan Maimaiti; Naohiko Anzai; Tomohiko Ichikawa
Journal:  Cancers (Basel)       Date:  2022-01-04       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.